Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme

Glioblastoma Multiforme (GBM) is the most common malignant primary brain tumor. Despite aggressive multimodality treatment it remains one of the most challenging and intractable cancers (1]. While current standard of care treatment for GBM is maximal safe surgical resection, systemic chemotherapy wi...

Full description

Bibliographic Details
Main Authors: Chin, Christopher, Lunking, Emma S., de la Fuente, Macarena, Ayad, Nagi G.
Format: Online Article Text
Language:English
Published: Frontiers Media S.A. 2018
Subjects:
Oncology
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243054/
https://www.ncbi.nlm.nih.gov/pubmed/30483476
http://dx.doi.org/10.3389/fonc.2018.00521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243054/
https://www.ncbi.nlm.nih.gov/pubmed/30483476
http://dx.doi.org/10.3389/fonc.2018.00521

Similar Items